“…DA agonists and antagonists increase and decrease EBRs, respectively in animals (Korsgaard et al, 1985; Elsworth et al, 1991; Lawrence and Redmond, 1991; Kleven and Koek, 1996; Kaminer et al, 2011) and humans (Blin et al, 1990; Strakowski et al, 1996; Strakowski and Sax, 1998). Additionally, hypo-dopaminergic conditions like Parkinson's lead to a reduction of the spontaneous blink rate (Karson, 1983; Karson et al, 1984; Korosec et al, 2006), while hyper-dopaminergic conditions like schizophrenia lead to an increase of the spontaneous blink rate (Cheung et al, 1995; Chen et al, 1996). So far, several studies have used the EBR as a behavioral index of DA functioning, predicting performance in DA-dependent cognitive tasks (Dreisbach et al, 2005; Colzato et al, 2007, 2008, 2009; Chermahini and Hommel, 2010; Akbari Chermahini and Hommel, 2012; Dang et al, 2016).…”